A Panel of Kallikrein Markers Can Reduce Unnecessary Biopsy for Prostate Cancer: Data From the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
BMC Medicine - United Kingdom
doi 10.1186/1741-7015-6-19
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 8, 2008
Authors
Publisher
Springer Science and Business Media LLC